Orencia (abatacept) subcutaneous medicines shortages have resolved

The pharmaceutical company Bristol-Myers Squibb Australia (BMS) has notified us that the shortages of both abatacept subcutaneous presentations have resolved. Supply has returned to normal. 

Go to the Medicine Shortage Reports Database- external site- external site for details.